Company Profiles

driven by the PitchBook Platform

AcuCort

2010 FOUNDED
PUBLIC STATUS
Angel LATEST DEAL TYPE
$688k LATEST DEAL AMOUNT
$688k TOTAL AMOUNT RAISED
1 INVESTORS
Description

Developer of fast dissolving glucocorticoids. The company provides a soluble film containing an anti-inflammatory glucocorticoid to be administered to the oral cavity during acute allergic reactions.

Website:
Ownership Status
Publicly Held
Financing Status
Accelerator/Incubator Backed
Primary Industry
Therapeutic Devices
Primary Office
Kullagatan 8
252 20 Helsingborg
Sweden
+46 (0)70 265 48 62
Request full access to PitchBook

You’re viewing a free company profile from the PitchBook Platform. To explore AcuCort’s full profile, request a free trial.

AcuCort Valuation and Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
2. Angel (individual) 17-Jun-2014 $688k $688k Completed Startup
1. Accelerator/Incubator Completed Startup
To view this company’s complete deal history including valuation and funding request access »

AcuCort Investors (1)

Investor Name Investor Type Holding Investor Since Participating Rounds Board
Seat
Contact
Info
Partners for Development Investments in Life Sciences Accelerator/Incubator Minority 000 0000 000000 0

AcuCort Executive Team (4)

Name Title Board
Seat
Contact
Info
Jörgen Johnsson Co-Founder & Vice Chairman
Gudmundur Johannsson Co-Founder
Hans Lennernäs Co-Founder
Thomas Hedner Co-Founder

AcuCort Board Members (7)

Name Representing Role Since Contact
Info
Bengt-Åke Bengtsson Ph.D Self Board Member 000 0000
Göran Kvist Self Board Member 000 0000
Jörgen Johnsson Self Board Member 000 0000
Jörgen Johnsson AcuCort Co-Founder & Vice Chairman 000 0000
Lennart Bruce Ph.D Self Board Member 000 0000
You’re viewing 5 of 7 board members. Get the full list »